| 摘要 |
A COMPOUND OF STRUCTURAL FORMULA I:OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF WHEREIN:Y IS CHOOSEN FROM A-N AS DEFINED HEREIN; WHEREIN EACH OCCURRENCE OF SAID C1-6 ALKYL MAY BE SUBSTITUTED WITH ONE OR MORE F, CL, BR, I, OR1, CO2R1, CN, SR1, OR R1 (WHERE R1 IS A HYDROGEN OR C1-4 ALKYL); X AND Z ARE INDEPENDENTLY C1-6 ALKYL, C3-12 CYCLOALKYL OR HYDROGEN, OR X AND Z FORM A C0-3 BRIDGING GROUP, PREFERABLY X AND Z ARE HYDROGEN; U, V AND W ARE INDEPENDENTLY C1-6 ALKYL, F, CL, BR, HYDROGEN OR A C1-6 ALKYL SUBSTITUTED WITH ONE OR MORE OF F, CI, BR OR I, PREFERABLY U AND V ARE F AND W IS HYDROGEN; R IS HYDROGEN, C1-12 ALKYL, C3-12 CYCLOALKYL, C1-6 ALKOXY, C1-6 ALKYL SUBSTITUTED WITH ONE OR MORE F, CL, BR, I OR OH; AND Q IS 0 TO 4 INCLUSIVE. OXAZOLIDINONE DERIVATIVES POSSESSING A SUBSTITUTED DIAZINE MOIETY BONDED TO THE N-ARYL RING AREUSEFUL ANTIMICROBIAL AGENTS, EFFECTIVE AGAINST A NUMBER OF HUMAN AND VETERINARY PATHOGENS, INCLUDING MULTIPLY-RESISTANT STAPHYLOCOCCI AND STREPTOCOCCI, AS WELL AS ANAEROBIC ORGANISMS SUCH AS BACTEROIDES AND CLOSTRIDIA SPECIES, AND ACID-FAST ORGANISMS SUCH AS MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM AVIUM.
|
